Prognostic value of tumor burden in nasopharyngeal carcinoma

Autor: Chen CB, Fei ZD, Huang CX, Ding JM, Chen LS

Publikováno v: Cancer Management and Research, Vol Volume 10, Pp 3169-3175 (2018)

Chuanben Chen,1,2 Zhaodong Fei,1,2 Chaoxiong Huang,2 Jianming Ding,1,2 Lisha Chen1,2 1Department of Radiation Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, Fujian, People’s Republic of China; 2Provincial Clini

Externí odkaz: https://doaj.org/article/c496247c704e4ec89c55759dd8863ac9

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Role of PET/CT in improving the cost effectiveness of nimotuzumab in nasopharyngeal carcinoma.

Autor: Fu XB; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.; Department of Radiation Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China., Li TT; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.; Department of Radiation Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China., Fei ZD; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China., Chen CB; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.

Publikováno v: Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale [Acta Otorhinolaryngol Ital] 2024 Oct; Vol. 44 (5), pp. 296-305.

Which evaluation criteria of the short-term efficacy can better reflect the long-term outcomes for patients with nasopharyngeal carcinoma?

Autor: Ma LQ; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou 350014, China; College of Clinical Medicine for Oncology, Fujian Medical University, Fuzhou 350128, China. Electronic address: maliqin3@126.com., Wu HX; College of Clinical Medicine for Oncology, Fujian Medical University, Fuzhou 350128, China., Kong XQ; Department of Radiation Oncology, Xiamen Humanity Hospital Fujian Medical University, Xiamen 361016, China., Fei ZD; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou 350014, China., Fang WN; Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou 350014, China., Du KX; Department of Radiation Oncology, Xiamen Humanity Hospital Fujian Medical University, Xiamen 361016, China., Chen F; College of Clinical Medicine for Oncology, Fujian Medical University, Fuzhou 350128, China., Zhao D; College of Clinical Medicine for Oncology, Fujian Medical University, Fuzhou 350128, China., Wu ZP; College of Clinical Medicine for Oncology, Fujian Medical University, Fuzhou 350128, China.

Publikováno v: Translational oncology [Transl Oncol] 2022 Jun; Vol. 20, pp. 101412. Date of Electronic Publication: 2022 Apr 05.